tiprankstipranks
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
US Market

Royalty Pharma (RPRX) Financial Statements

Compare
1,248 Followers

Royalty Pharma Financial Overview

Royalty Pharma's market cap is currently $18.94B. The company's EPS TTM is $1.917; its P/E ratio is 17.18; and it has a dividend yield of 2.58%. Royalty Pharma is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $1.07. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 2.26B$ 2.35B$ 2.24B$ 2.29B$ 2.12B
Gross Profit$ 2.26B$ 1.79B$ 2.23B$ 2.27B$ 2.03B
Operating Income$ 1.29B$ 1.49B$ 977.50M$ 1.43B$ 1.59B
EBITDA$ 1.29B$ 1.89B$ 928.56M$ 1.45B$ 1.68B
Net Income$ 859.00M$ 1.13B$ 42.83M$ 478.75M$ 495.20M
Balance Sheet
Cash & Short-Term Investments$ 987.23M$ 495.31M$ 2.43B$ 2.80B$ 1.99B
Total Assets$ 18.22B$ 16.38B$ 16.81B$ 17.52B$ 21.10B
Total Debt$ 7.61B$ 6.14B$ 7.12B$ 7.10B$ 5.82B
Net Debt$ 6.68B$ 5.66B$ 5.41B$ 5.56B$ 4.81B
Total Liabilities$ 7.88B$ 6.30B$ 7.29B$ 7.27B$ 6.12B
Stockholders' Equity$ 10.34B$ 6.53B$ 5.63B$ 5.78B$ 9.90B
Cash Flow
Free Cash Flow$ 2.77B$ 2.99B$ 4.19B$ 2.02B$ 4.23B
Operating Cash Flow$ 2.77B$ 2.99B$ 2.14B$ 2.02B$ 2.03B
Investing Cash Flow$ -2.68B$ -2.07B$ -1.03B$ -1.87B$ -2.76B
Financing Cash Flow$ 361.14M$ -2.15B$ -944.86M$ 385.11M$ 1.49B
Currency in USD

Royalty Pharma Earnings and Revenue History

Royalty Pharma Debt to Assets

Royalty Pharma Cash Flow

Royalty Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis